⌘K

Login Start Free

Home/Filings/4/0001127602-24-001943

4//SEC Filing

Eisele Jeffrey 4

Accession 0001127602-24-001943

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 6:05 PM ET

Size

4.5 KB

Accession

0001127602-24-001943

Insider Transaction Report

Form 4

Period: 2024-01-22

Apellis Pharmaceuticals, Inc.APLS

Chief Development Officer

Transactions

Sale
Common Stock
2024-01-22$65.00/sh−1,607$104,449→ 65,836 total

Footnotes (1)

[F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/19/2024.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1

filerCIK 0001827326

Filing Metadata

Form type: 4
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 6:05 PM ET
Size: 4.5 KB

View on SEC.gov